
James O. Wilson
Supervisory Patent Examiner (ID: 8201, Phone: (571)272-0661 , Office: P/1624 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | DCPO, 1623, 1624, 1211, 1803, 1622 |
| Total Applications | 1025 |
| Issued Applications | 636 |
| Pending Applications | 173 |
| Abandoned Applications | 216 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1496121
[patent_doc_number] => 06403777
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Metalloligands for cleaving nucleic acids'
[patent_app_type] => B1
[patent_app_number] => 09/348225
[patent_app_country] => US
[patent_app_date] => 1999-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4574
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403777.pdf
[firstpage_image] =>[orig_patent_app_number] => 09348225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/348225 | Metalloligands for cleaving nucleic acids | Jul 5, 1999 | Issued |
Array
(
[id] => 4314238
[patent_doc_number] => 06242429
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Arabinosyladenine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/339257
[patent_app_country] => US
[patent_app_date] => 1999-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7399
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242429.pdf
[firstpage_image] =>[orig_patent_app_number] => 339257
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339257 | Arabinosyladenine derivatives | Jun 23, 1999 | Issued |
Array
(
[id] => 4349833
[patent_doc_number] => 06214807
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'C-pyrazole 2A A receptor agonists'
[patent_app_type] => 1
[patent_app_number] => 9/338327
[patent_app_country] => US
[patent_app_date] => 1999-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8387
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214807.pdf
[firstpage_image] =>[orig_patent_app_number] => 338327
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/338327 | C-pyrazole 2A A receptor agonists | Jun 21, 1999 | Issued |
| 09/332479 | USE OF ADENOSINE TO MINIMIZE REPERFUSION INJURY | Jun 13, 1999 | Abandoned |
Array
(
[id] => 4184073
[patent_doc_number] => 06150341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Vitamin B.sub.12 derivatives and methods for their preparation'
[patent_app_type] => 1
[patent_app_number] => 9/330167
[patent_app_country] => US
[patent_app_date] => 1999-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6616
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150341.pdf
[firstpage_image] =>[orig_patent_app_number] => 330167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/330167 | Vitamin B.sub.12 derivatives and methods for their preparation | Jun 10, 1999 | Issued |
Array
(
[id] => 4219316
[patent_doc_number] => 06111097
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Process for producing carboxypolysaccharide'
[patent_app_type] => 1
[patent_app_number] => 9/325878
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6706
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/111/06111097.pdf
[firstpage_image] =>[orig_patent_app_number] => 325878
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325878 | Process for producing carboxypolysaccharide | Jun 3, 1999 | Issued |
Array
(
[id] => 4314959
[patent_doc_number] => 06316615
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Process for the recovery of potassium bitartrate and other products from tamarind pulp'
[patent_app_type] => 1
[patent_app_number] => 9/323478
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4848
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 441
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316615.pdf
[firstpage_image] =>[orig_patent_app_number] => 323478
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/323478 | Process for the recovery of potassium bitartrate and other products from tamarind pulp | May 31, 1999 | Issued |
Array
(
[id] => 4272590
[patent_doc_number] => 06323187
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Therapeutic dinucleotide and derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/316571
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5416
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323187.pdf
[firstpage_image] =>[orig_patent_app_number] => 316571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316571 | Therapeutic dinucleotide and derivatives | May 20, 1999 | Issued |
Array
(
[id] => 4324302
[patent_doc_number] => 06331618
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Compositions of solvents and high concentrations of nucleic acid analogs'
[patent_app_type] => 1
[patent_app_number] => 9/311079
[patent_app_country] => US
[patent_app_date] => 1999-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5347
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331618.pdf
[firstpage_image] =>[orig_patent_app_number] => 311079
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/311079 | Compositions of solvents and high concentrations of nucleic acid analogs | May 12, 1999 | Issued |
Array
(
[id] => 1447315
[patent_doc_number] => 06369209
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Oligonucleotides having A-DNA form and B-DNA form conformational geometry'
[patent_app_type] => B1
[patent_app_number] => 09/303586
[patent_app_country] => US
[patent_app_date] => 1999-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 38274
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09303586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/303586 | Oligonucleotides having A-DNA form and B-DNA form conformational geometry | May 2, 1999 | Issued |
Array
(
[id] => 1575765
[patent_doc_number] => 06469159
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues'
[patent_app_type] => B1
[patent_app_number] => 09/301374
[patent_app_country] => US
[patent_app_date] => 1999-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4591
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469159.pdf
[firstpage_image] =>[orig_patent_app_number] => 09301374
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301374 | Methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues | Apr 25, 1999 | Issued |
Array
(
[id] => 1417572
[patent_doc_number] => 06509322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-21
[patent_title] => 'Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/290873
[patent_app_country] => US
[patent_app_date] => 1999-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4085
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09290873
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/290873 | Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives | Apr 13, 1999 | Issued |
Array
(
[id] => 4314235
[patent_doc_number] => 06248347
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Calcium assimilation accelerator and calcium-supplementing diet comprising and a method for accelerating calcium assimilation'
[patent_app_type] => 1
[patent_app_number] => 9/289728
[patent_app_country] => US
[patent_app_date] => 1999-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248347.pdf
[firstpage_image] =>[orig_patent_app_number] => 289728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/289728 | Calcium assimilation accelerator and calcium-supplementing diet comprising and a method for accelerating calcium assimilation | Apr 11, 1999 | Issued |
Array
(
[id] => 4360642
[patent_doc_number] => 06175006
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Automated system for polynucleotide synthesis and purification'
[patent_app_type] => 1
[patent_app_number] => 9/281205
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6632
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/175/06175006.pdf
[firstpage_image] =>[orig_patent_app_number] => 281205
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/281205 | Automated system for polynucleotide synthesis and purification | Mar 29, 1999 | Issued |
Array
(
[id] => 4188732
[patent_doc_number] => 06093807
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Sugar-modified 7-deaza-7-substituted oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 9/272977
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6254
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093807.pdf
[firstpage_image] =>[orig_patent_app_number] => 272977
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/272977 | Sugar-modified 7-deaza-7-substituted oligonucleotides | Mar 18, 1999 | Issued |
Array
(
[id] => 4329027
[patent_doc_number] => 06329519
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Intermediates for oligonucleotide synthesis'
[patent_app_type] => 1
[patent_app_number] => 9/202294
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329519.pdf
[firstpage_image] =>[orig_patent_app_number] => 202294
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202294 | Intermediates for oligonucleotide synthesis | Mar 14, 1999 | Issued |
Array
(
[id] => 4131600
[patent_doc_number] => 06034055
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars'
[patent_app_type] => 1
[patent_app_number] => 9/255642
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6863
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034055.pdf
[firstpage_image] =>[orig_patent_app_number] => 255642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255642 | Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars | Feb 21, 1999 | Issued |
Array
(
[id] => 4398839
[patent_doc_number] => 06297371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy'
[patent_app_type] => 1
[patent_app_number] => 9/253702
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5527
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297371.pdf
[firstpage_image] =>[orig_patent_app_number] => 253702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/253702 | Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy | Feb 21, 1999 | Issued |
Array
(
[id] => 1467234
[patent_doc_number] => 06458772
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Prodrugs'
[patent_app_type] => B1
[patent_app_number] => 09/249317
[patent_app_country] => US
[patent_app_date] => 1999-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 95205
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458772.pdf
[firstpage_image] =>[orig_patent_app_number] => 09249317
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249317 | Prodrugs | Feb 11, 1999 | Issued |
Array
(
[id] => 4298328
[patent_doc_number] => 06197950
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Cationized hydroxyalkylcellulose and process for producing the same'
[patent_app_type] => 1
[patent_app_number] => 9/246247
[patent_app_country] => US
[patent_app_date] => 1999-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2999
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197950.pdf
[firstpage_image] =>[orig_patent_app_number] => 246247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/246247 | Cationized hydroxyalkylcellulose and process for producing the same | Feb 7, 1999 | Issued |